Immunogenicity and Safety Evaluation of QIS in Healthy Subjects
Clinical trial NCT04101435 · COMPLETED
Trial details
- NCT number
- NCT04101435
- Sponsor
- Adimmune Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-28
- Primary completion
- 2017-07-12
- Enrollment
- 174
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.